AccuSift High-Performance Central Nervous System Specific Protein (S100-β) Antibody PairAccuSift provides high-performance Central Nervous System Specific Protein (S100-β) antibody pairs with exceptional lot-to-lot consistency, specifically optimized for the development of IVD kits (Lateral Flow, Chemiluminescence, ELISA, POCT). Featuring high affinity and specificity, they facilitate rapid detection.The measurement of the central nervous system-specific protein S100-β serves as a biochemical marker for brain injury. It holds significant importance for the early diagnosis, prognosis assessment, identification of treatment approaches, and adjustment of therapeutic strategies for brain injury.Clinically, the S100-β test primarily assists in evaluating conditions related to brain neural tissue damage, such as traumatic brain injury, acute stroke, brain tumors, neonatal hypoxic-ischemic encephalopathy, encephalitis, central nervous system infections, and psychiatric disorders.The S100-β assay carries substantial clinical value for managing cerebrovascular diseases, diagnosing brain injury, assessing its severity, and determining prognosis. Furthermore, it plays a significant role in diagnosing central nervous system damage resulting from CNS disorders and psychiatric conditions.Source: Mouse Monoclonal Antibodies
Recommended Pairing: (Coating) / (Labeling)Storage: For long-term storage, keep at ≤ -20°C; for short-term storage, keep at 2-8°C. Shipped with ice packs.
WeChat
